Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer
The aim of the study is to determine if Iressa is effective in the treatment of Brain metastases from NCSLC
Brain Neoplasms|Non Small Cell Lung Cancer
DRUG: Iressa (Gefitinib)
Disease control rate (complete response, partial response and stable disease)
Duration of response|Time to progression|Overall Survival
The aim of the study is to determine if Iressa is effective in the treatment of Brain metastases from NCSLC